Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Lynch Syndrome | Kisho | Kisho

Back to Lynch Syndrome

Lynch Syndrome — NIH Grants & Funding

Active and recent NIH-funded research on Lynch Syndrome. Data from NIH RePORTER, last 36 months.

MONDO:0005835

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Lynch Syndrome has a robust NIH research funding landscape with 27 funded grants and $29.9M in total funding over the period.

27funded grants from NIH

Portfolio: $12.5MCumulative: $29.9M12 active15 completed32 PIs19 institutions

By Research Theme

Clinical

Basic Science

Translational

Epi / Nat. History

Biomarker / Dx

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$9.7M

FY22

$6.5M

FY23

$7.3M

FY24

$6.3M

FY25

By Funding Mechanism

R01

N01

R21

K99

R00

R16

Adjacent Research(20 grants)

These grants mention Lynch Syndrome as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(20)

OtherU01Active

Population Genomics Screening Network (PGSN) Coordinating Center

Rice, Kenneth·UNIVERSITY OF WASHINGTON·SEATTLE, WA

$2,114,800 (FY2026)

NIH RePORTER

OtherUG1Active

Northwestern Cancer Prevention Consortium

KHAN, SEEMA·NORTHWESTERN UNIVERSITY AT CHICAGO·CHICAGO, IL

$1,870,000 (FY2025)

NIH RePORTER

OtherUG1Active

Early Phase Clinical Cancer Prevention Consortium

Djuric, Zora et al.·UNIVERSITY OF MICHIGAN AT ANN ARBOR·ANN ARBOR, MI

$1,449,424 (FY2025)

NIH RePORTER

OtherN01Completed

FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION

ROBINSON, PREMA·UNIVERSITY OF TX MD ANDERSON CAN CTR·HOUSTON, TX

$1,293,012 (FY2023)

NIH RePORTER

OtherR01Active

Rational Integration of Polygenic Risk Scores (RIPS)

Hao, Jing et al.·VANDERBILT UNIVERSITY MEDICAL CENTER·NASHVILLE, TN

$863,677 (FY2026)

NIH RePORTER

OtherR01Active

Facilitating the Implementation of Population-wide Genomic Screening (FOCUS)

Allen, Caitlin et al.·WAKE FOREST UNIVERSITY HEALTH SCIENCES·WINSTON-SALEM, NC

$757,994 (FY2025)

NIH RePORTER

OtherR01Active

Design of a Scalable and Sustainable PREMMplus Patient-Facing App and Implementation in Three Healthcare Settings

SYNGAL, SAPNA·DANA-FARBER CANCER INST·BOSTON, MA

$689,204 (FY2025)

NIH RePORTER

OtherR01Active

Randomized Trial to Improve Care of Patients with Hereditary Cancer Syndromes

O'CONNOR, PATRICK·HEALTHPARTNERS INSTITUTE·Bloomington, MN

$656,446 (FY2025)

NIH RePORTER

OtherR01Active

Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study

KURIAN, ALLISON et al.·STANFORD UNIVERSITY·STANFORD, CA

$648,486 (FY2026)

NIH RePORTER

OtherK08Active

Piloting an Implementation Strategy for Mainstream Genetic Testing in Colorectal Cancer

Hollis, Robert·UNIVERSITY OF ALABAMA AT BIRMINGHAM·BIRMINGHAM, AL

$192,433 (FY2025)

NIH RePORTER

Kisho

Lynch Syndrome — NIH Grants & Funding

Funding Landscape

By Research Theme

Funding by Fiscal Year

By Funding Mechanism

Adjacent Research(20 grants)

Other(20)

Population Genomics Screening Network (PGSN) Coordinating Center

Northwestern Cancer Prevention Consortium

Early Phase Clinical Cancer Prevention Consortium

FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION

Rational Integration of Polygenic Risk Scores (RIPS)

Facilitating the Implementation of Population-wide Genomic Screening (FOCUS)

Design of a Scalable and Sustainable PREMMplus Patient-Facing App and Implementation in Three Healthcare Settings

Randomized Trial to Improve Care of Patients with Hereditary Cancer Syndromes

Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study

Piloting an Implementation Strategy for Mainstream Genetic Testing in Colorectal Cancer

Top Funded Institutions

Top Principal Investigators